Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR5 | Q9H228 | 8/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24919182 | 0.98 | S1PR5 (0.33) | S1PR5S1PR4HCRTR1CASP3SENP7 | |
| SCHEMBL25535123 | 0.98 | S1PR5 (0.33) | S1PR5S1PR4HCRTR1CASP3SENP7 | |
| SCHEMBL29303523 | 0.97 | S1PR5 (0.35) | S1PR5S1PR4HCRTR1ALOX5CASP3 | |
| SCHEMBL25535159 | 0.97 | S1PR5 (0.34) | S1PR5S1PR4HCRTR1CASP3SENP7 | |
| SCHEMBL25535659 | 0.97 | S1PR5 (0.37) | S1PR5S1PR4HCRTR1ALOX5CASP3 | |
| SCHEMBL24919104 | 0.95 | S1PR5 (0.34) | S1PR5S1PR4HCRTR1CASP3SENP7 | |
| SCHEMBL25535845 | 0.94 | S1PR5 (0.35) | S1PR5S1PR4HCRTR1ALOX5CASP3 | |
| SCHEMBL23180101 | 0.94 | S1PR5 (0.34) | S1PR5S1PR4HCRTR1ALOX5APP | |
| SCHEMBL24841629 | 0.94 | S1PR5 (0.34) | S1PR5S1PR4HCRTR1ALOX5APP | |
| SCHEMBL23180432 | 0.93 | S1PR5 (0.34) | S1PR5S1PR4HCRTR1CASP3SENP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | LEF1, PIEZO1, ELAVL1 | S1PR5 4533/4885S1PR4 3989/4885HCRTR1 3664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.